The goal of this research is to find out how safe and potentially effective the new drug obicetrapib is for…
Kimberley Halsall6 January 2022
The goal of this research is to find out how safe and effective the new…
Kimberley Halsall2 November 2021
A phase II, double-blind, randomized, placebo-controlled study, parallel-group, multicenter research on the safety and effectiveness…
Kimberley Halsall11 June 2021
A phase II, multicentre, double-blind, randomized, placebo-controlled study of the safety and efficacy of the…
Robin Veerman17 March 2021
An open-label, multicenter, follow-up study to evaluate the safety and tolerability of long-term administration of…
Robin Veerman16 March 2021
A phase III randomized, double-blind study comparing an existing treatment (teriflunomide) with a new one…
Robin Veerman16 March 2021
Phase IIIb, open-label, multicenter safety study of BIIB037 (aducanumab) in study participants with Alzheimer's disease…
Robin Veerman16 March 2021
A multicenter, open-label phase II study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of…
Robin Veerman16 March 2021
A phase II, double-blind, randomized, placebo-controlled trial of the safety, tolerability and effectiveness of Donanemab…
Robin Veerman1 March 2021
